[
  {
    "ts": null,
    "headline": "DexCom (DXCM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates",
    "summary": "Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=65d52c3cd50be5ff142361efef899c81801312f7795962317344c713e47093cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761859802,
      "headline": "DexCom (DXCM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates",
      "id": 137275395,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=65d52c3cd50be5ff142361efef899c81801312f7795962317344c713e47093cd"
    }
  },
  {
    "ts": null,
    "headline": "DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates",
    "summary": "DexCom (DXCM) delivered earnings and revenue surprises of +7.02% and +2.72%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=34ed3bf73e514f901214dc2c89796cc11eb817414b60ff78ec1ebb09fb3bb49c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761858601,
      "headline": "DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates",
      "id": 137275396,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DexCom (DXCM) delivered earnings and revenue surprises of +7.02% and +2.72%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=34ed3bf73e514f901214dc2c89796cc11eb817414b60ff78ec1ebb09fb3bb49c"
    }
  },
  {
    "ts": null,
    "headline": "DexCom, Inc. (DXCM) Q3 2025 Earnings Call Transcript",
    "summary": "DexCom, Inc. (DXCM) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsSean Christensen - Vice President of Finance and Investor...",
    "url": "https://finnhub.io/api/news?id=4c1a923324b22becfd88696dc8e414f3ebe264b4e975793950fdc62ff38d65f5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761855984,
      "headline": "DexCom, Inc. (DXCM) Q3 2025 Earnings Call Transcript",
      "id": 137272759,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "DXCM",
      "source": "SeekingAlpha",
      "summary": "DexCom, Inc. (DXCM) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsSean Christensen - Vice President of Finance and Investor...",
      "url": "https://finnhub.io/api/news?id=4c1a923324b22becfd88696dc8e414f3ebe264b4e975793950fdc62ff38d65f5"
    }
  },
  {
    "ts": null,
    "headline": "DexCom (NASDAQ:DXCM) Beats Q3 Sales Expectations But Stock Drops",
    "summary": "Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q3 CY2025, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s revenue to be around $4.64 billion, close to analysts’ estimates. Its non-GAAP profit of $0.61 per share was 7.5% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=6a8989191c0b81d692704565512cef84f3302d4a44500d5cddb56f0e97f59de9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761855378,
      "headline": "DexCom (NASDAQ:DXCM) Beats Q3 Sales Expectations But Stock Drops",
      "id": 137275397,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q3 CY2025, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s revenue to be around $4.64 billion, close to analysts’ estimates. Its non-GAAP profit of $0.61 per share was 7.5% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=6a8989191c0b81d692704565512cef84f3302d4a44500d5cddb56f0e97f59de9"
    }
  },
  {
    "ts": null,
    "headline": "DexCom: Q3 Earnings Snapshot",
    "summary": "The San Diego-based company said it had net income of 70 cents per share. Earnings, adjusted for non-recurring gains, were 61 cents per share. The results surpassed Wall Street expectations.",
    "url": "https://finnhub.io/api/news?id=ca7eb57f19c7132eda70a0c12279f926828fbcaaaca21f4ca433736fb9f1f9f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761854870,
      "headline": "DexCom: Q3 Earnings Snapshot",
      "id": 137269618,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "The San Diego-based company said it had net income of 70 cents per share. Earnings, adjusted for non-recurring gains, were 61 cents per share. The results surpassed Wall Street expectations.",
      "url": "https://finnhub.io/api/news?id=ca7eb57f19c7132eda70a0c12279f926828fbcaaaca21f4ca433736fb9f1f9f1"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance",
    "summary": "SAN DIEGO, October 30, 2025--Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance",
    "url": "https://finnhub.io/api/news?id=8c19eb80d2b3a2485c28624d62ab89e4985f2b051db2e3ddbbc40da008bb6a44",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761854520,
      "headline": "Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance",
      "id": 137269619,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "SAN DIEGO, October 30, 2025--Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance",
      "url": "https://finnhub.io/api/news?id=8c19eb80d2b3a2485c28624d62ab89e4985f2b051db2e3ddbbc40da008bb6a44"
    }
  },
  {
    "ts": null,
    "headline": "DexCom, Inc. 2025 Q3 - Results - Earnings Call Presentation",
    "summary": "2025-10-30. The following slide deck was published by DexCom, Inc.",
    "url": "https://finnhub.io/api/news?id=b6a63b4ee7f6e11012be0096573943a7a83a22632fdb773172331095ed3c3a53",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761843664,
      "headline": "DexCom, Inc. 2025 Q3 - Results - Earnings Call Presentation",
      "id": 137271208,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "DXCM",
      "source": "SeekingAlpha",
      "summary": "2025-10-30. The following slide deck was published by DexCom, Inc.",
      "url": "https://finnhub.io/api/news?id=b6a63b4ee7f6e11012be0096573943a7a83a22632fdb773172331095ed3c3a53"
    }
  },
  {
    "ts": null,
    "headline": "Truist Lowers DexCom (DXCM) PT to $94 Ahead of Q3 MedTech Sector Preview, Maintains Buy Rating",
    "summary": "DexCom Inc. (NASDAQ:DXCM) is one of the best NASDAQ growth stocks to buy for the next 5 years. On October 15, Truist analyst Richard Newitter lowered the firm’s price target on DexCom to $94 from $102 with a Buy rating on the shares as part of the firm’s broader research note previewing Q3 2025 results […]",
    "url": "https://finnhub.io/api/news?id=e82a7cb804f5d9c707003167158272e9b53fd7e636e4914960c4aaa495d4d400",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761831065,
      "headline": "Truist Lowers DexCom (DXCM) PT to $94 Ahead of Q3 MedTech Sector Preview, Maintains Buy Rating",
      "id": 137266901,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DexCom Inc. (NASDAQ:DXCM) is one of the best NASDAQ growth stocks to buy for the next 5 years. On October 15, Truist analyst Richard Newitter lowered the firm’s price target on DexCom to $94 from $102 with a Buy rating on the shares as part of the firm’s broader research note previewing Q3 2025 results […]",
      "url": "https://finnhub.io/api/news?id=e82a7cb804f5d9c707003167158272e9b53fd7e636e4914960c4aaa495d4d400"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy DexCom Stock Before Oct. 31?",
    "summary": "The company hasn't had a great year. Is it about to turn things around?",
    "url": "https://finnhub.io/api/news?id=e2944241f7225fdb78541001003ada856f1fc0cd69c9237ea1787e63e675985f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761830580,
      "headline": "Should You Buy DexCom Stock Before Oct. 31?",
      "id": 137267048,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "The company hasn't had a great year. Is it about to turn things around?",
      "url": "https://finnhub.io/api/news?id=e2944241f7225fdb78541001003ada856f1fc0cd69c9237ea1787e63e675985f"
    }
  }
]